Exploring Bioethics - NIH Office of Science Education - National ...

More documents

Recommendations

Info

This curriculum supplementwas developed collaborativelyby EDC and the NationalInstitutes of Health underNIH contract numberHHSN263200600017C.Department of Health andHuman Services200 Independence Avenue, S.W.Washington, DC 20201http://www.dhhs.govDepartment of BioethicsClinical CenterNational Institutes of Health10 Center Drive, Building 10Room 1C118Bethesda, MD 20892-1156http://www.bioethics.nih.govOffice of Science EducationNational Institutes of Health6100 Executive Boulevard, Suite 3E01Bethesda, MD 20892-7520http://science.education.nih.govCenter for Applied Ethics andCenter for Science EducationEducation Development Center, Inc.55 Chapel StreetNewton, MA 02458-1060http://www.edc.orgApril 2009NIH Publication No. 9-7386
Page 1 and 2:
NIH CurriculumSupplement SeriesGrad
Page 3 and 4:
Education Development Center, Inc.D
Page 5 and 6:
This material is based on work supp
Page 7 and 8:
About the National Institutes of He
Page 10:
Introduction
Page 13 and 14:
activity of assessing different rea
Page 15 and 16:
teaching strategies that will help
Page 17 and 18:
2. The ability to distinguish an et
Page 19 and 20:
quence of choosing one path over an
Page 21 and 22:
Table 1. Assessing Student Justific
Page 23 and 24:
Challenges in TeachingBioethics and
Page 25 and 26:
How Exploring Bioethics Can HelpFor
Page 27 and 28:
Prompts to encourage students to re
Page 29 and 30:
Table 2d. Students say they already
Page 31 and 32:
Resources forTeaching BioethicsBeau
Page 33 and 34:
Table 3. Ethical Issues and Curricu
Page 35 and 36:
Each module is divided into three d
Page 37 and 38:
Table 4. Alignment with NSES Life S
Page 39 and 40:
About the Web SiteThe Web site for
Page 42 and 43:
1Module 1Bioethics Concepts and Ski
Page 44 and 45:
• apply important ethical conside
Page 46 and 47:
In Advance1Copies, Equipment, and M
Page 48 and 49:
Teaching Sequence1Day 1: What’s i
Page 50 and 51:
new medication, she is able to stay
Page 52 and 53:
6. Read the list of Round 1 questio
Page 54 and 55:
• With respect to performance enh
Page 56 and 57:
LE/LE/LLE/LPoint out that some of t
Page 58 and 59:
Organizer for Day 1: What’s in a
Page 60 and 61:
Day 2: Four Key Questions1PurposeDa
Page 62 and 63:
4. Emphasize that when bioethicists
Page 64 and 65:
15. Ask students to list as many et
Page 66 and 67:
Organizer for Day 2: Four Key Quest
Page 68 and 69:
Encourage students to share example
Page 70 and 71:
Activity 7:Using Ethical Considerat
Page 72 and 73:
4. Ask a representative from each g
Page 74 and 75:
Organizer for Day 3: Core Ethical C
Page 76 and 77:
References and Resources1Informatio
Page 78 and 79:
What Type of Question? ROUND 1—Et
Page 80 and 81:
What Type of Question? ROUND 3: Eth
Page 82 and 83:
Round 4Q9Should embryonic stem cell
Page 84 and 85:
Oscar Pistorius—The Fastest Man w
Page 86 and 87:
Four Key Questions and Statementof
Page 88 and 89:
Carl’s CaseCarl listened to his t
Page 90 and 91:
1Module 2Balancing Individual and C
Page 92 and 93:
adopting vaccination policies that
Page 94 and 95:
In Advance1Copies, Equipment, and M
Page 96 and 97:
Teaching Sequence1Day 1: Exploring
Page 98 and 99:
the key stakeholders, and taken int
Page 100 and 101:
You may wish to highlight the dange
Page 102 and 103:
ClosureAsk students to reflect on t
Page 104 and 105:
Day 2: Community Immunity1PurposeOn
Page 106 and 107:
10. Ask all students in the class t
Page 108 and 109:
• While an unvaccinated person’
Page 110 and 111:
ClosureRecap for students that the
Page 112 and 113:
Tell only the students who were tag
Page 114 and 115:
5. Divide students into pairs, and
Page 116 and 117:
17. Share with students that becaus
Page 118 and 119:
13. Note that the Boston and Dublin
Page 120 and 121:
Teaching StrategiesYou may want to
Page 122 and 123:
Ask each member of the pair to read
Page 124 and 125:
1Centers for Disease Control and Pr
Page 126 and 127:
Get Kids Vaccinated or ElseGet Kids
Page 128 and 129:
Name(s)Station 2—Vaccine RisksDir
Page 130 and 131:
Station 1: Vaccine-Preventable Dise
Page 132 and 133:
MumpsBefore the mumps vaccine was i
Page 134 and 135:
Station 2—Vaccine RisksNote: Like
Page 136 and 137:
Smallpox VaccineThe smallpox vaccin
Page 138 and 139:
Station 4—ExemptionsExemptions vs
Page 140 and 141:
State Exemptions Allowed as of Fall
Page 142 and 143:
Name(s)What are the ethical conside
Page 144 and 145:
Vaccination Status CardsVaccinated
Page 146 and 147:
Opting Out of a Vaccine—Variables
Page 148 and 149:
Measles in DublinIn 2000, an outbre
Page 150:
What are some of the different pers
Page 153 and 154:
Issues Explored• What is the fair
Page 155 and 156:
Day 3—What Is Your Recommendation
Page 157 and 158:
Teaching SequenceNoteAssign this ho
Page 159 and 160:
Teaching Strategies: Jigsaw Techniq
Page 161 and 162:
Some students might think that the
Page 163 and 164:
11. Explain to students that they w
Page 165 and 166:
Inform students that they will now
Page 167 and 168:
2. Tell them that one liver has bec
Page 169 and 170:
6. If it does not naturally arise,
Page 171 and 172:
Criteria relevant to allocating liv
Page 173 and 174:
Organizer for Day 2: Identifying St
Page 175 and 176:
Day 3: What Is Your Recommendation?
Page 177 and 178:
Activity 9:Understanding Past and C
Page 179 and 180:
ClosureReinforce to students that t
Page 181 and 182:
Ask students whether they think the
Page 183 and 184:
Liver Function and FailureHepatitis
Page 185 and 186:
Name(s)Banting decided that he woul
Page 187 and 188:
Name(s)The COC distributed the peni
Page 189 and 190:
Name(s)The Admissions and Policy Co
Page 191 and 192:
Liver and Liver-Transplant Fact She
Page 193 and 194:
The Liver and Liver Transplants—C
Page 195 and 196:
Patient ProfilesAnitaAnita is a 19-
Page 197 and 198:
Additional Patient InformationAnita
Page 199 and 200:
The United Network for Organ Sharin
Page 201 and 202:
Comparing the Past and Current UNOS
Page 204 and 205:
1Module 4Weighing Benefits and Harm
Page 206 and 207:
An optional extension activity incl
Page 208 and 209:
In Advance1Preparing the Envelopes
Page 210 and 211:
Teaching Sequence1Day 1: Deciding t
Page 212 and 213:
6. Explain that each student should
Page 214 and 215:
Activity 2:Introducing Max’s Thyr
Page 216 and 217:
See Teacher Support MaterialsSupple
Page 218 and 219:
ClosureTo close the class, remind s
Page 220 and 221:
1Activity 2: Introducing Max’s Th
Page 222 and 223:
Activity 5:Who or What Will Be Affe
Page 224 and 225:
Activity 6:Exploring the Relevant E
Page 226 and 227:
11. Give each student a copy of Mas
Page 228 and 229:
1Ask students, “What are some rea
Page 230 and 231:
5. Have students, in pairs, quickly
Page 232 and 233:
ReflectionDisplay the posters from
Page 234 and 235:
1Reflection: Have students view the
Page 236:
1Retinitis PigmentosaFoundation Fig
Page 239 and 240:
Alzheimer’s Disease and Genetic T
Page 241 and 242:
Name(s)Now, on your own, answer the
Page 243 and 244:
Name(s)Max’s Family Tree on His M
Page 245 and 246:
Genetic Testing—Key Concepts• S
Page 247 and 248:
What Impact Would Max’s Newly Dis
Page 249 and 250:
Your Tentative ThoughtsName(s)1. Do
Page 251 and 252:
Ethical Questions• Who should dec
Page 253 and 254:
Extension (Optional)About Retinitis
Page 255 and 256:
Issues Explored• Why is it import
Page 257 and 258:
Key Science Knowledge*• Nature of
Page 259 and 260:
Teaching SequenceDay 1: Research wi
Page 261 and 262:
13. Ask students, “Should I just
Page 263 and 264:
Some students in the treatment grou
Page 265 and 266:
it is ethically acceptable. For exa
Page 267 and 268:
Students should recognize that rese
Page 269 and 270:
ClosureAsk the class whether they t
Page 271 and 272:
Organizer for Day 1: Research with
Page 273 and 274:
Activity 4: Returning to Your Decis
Page 275 and 276:
5. Discuss the results with the who
Page 277 and 278:
5. Summarize two key points about r
Page 279 and 280:
• The Belmont Report has served a
Page 281 and 282:
Organizer for Day 2:Harms and Benef
Page 283 and 284:
Day 3: Analyzing the Willowbrook Ca
Page 285 and 286:
Deciding on and Recording Main Poin
Page 287 and 288:
Organizer for Day 3: Analyzing the
Page 289 and 290:
Willowbrook StudyCenters for Diseas
Page 291 and 292:
Asthma Simulation OutcomesYou were
Page 293 and 294:
Name(s)Reflection Questions1. Aside
Page 295 and 296:
Letter to ParentsThis is the letter
Page 297 and 298:
What Are the Relevant Ethical Consi
Page 299 and 300: Name(s)(Fill out with your partner.
Page 301 and 302: Name(s)(Fill out individually.)Your
Page 303 and 304: Issues Explored• Should there be
Page 305 and 306: Key Science Knowledge*• DNA, RNA,
Page 309 and 310: 4. Ask students for their prelimina
Page 311 and 312: 8. Tell students to come to the nex
Page 313 and 314: Day 2: Deepening Your Thinking—So
Page 316 and 317: You may wish to note that• Cases
Page 318 and 319: 2. Direct students to turn to their
Page 320 and 321: Organizer for Day 2: Deepening Your
Page 322 and 323: Day 3: Making a Recommendation—Se
Page 324 and 325: Those cases where students do not t
Page 326 and 327: 3. Ask a representative from each g
Page 328 and 329: Activity 9: Returning to Alba’s C
Page 330 and 331: 1Ear MiceBBC News. 2002. Artificial
Page 332 and 333: Alba’s CaseSince the early 1990s,
Page 334 and 335: Dyed FeathersPeople dye bird feathe
Page 336 and 337: Giant Panda BreedingThe giant panda
Page 338 and 339: Mad-Cow-Disease CowsMad cow disease
Page 340 and 341: Purebred DogsHumans have geneticall
Page 342 and 343: Spider-Silk GoatsSpider silk is str
Page 344 and 345: VealVeal is meat from calves that i
Page 346 and 347: Assessing Harms, Benefits, and Pote
Page 348 and 349: Final Assessment of Alba’s CaseRe
show all

Exploring Bioethics - NIH Office of Science Education - National ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?